ADIPOQ and prostate carcinoma: As recent studies have shown that cytokine stimulation from periprostatic adipose tissues enhances cancer aggressiveness in patients with prostate cancer [4] [20], we hypothesized that adiponectin secretion from perinephric adipose tissue modulates RCC aggressiveness by modulating the tumor microenvironment.